Navigation Links
Photocure Announces new Commercial Strategy for Hexvix(R), the Innovative Product for Improved Detection of Bladder Cancer
Date:9/26/2011

eholders."

Marc de Garidel, Ipsen's Chairman and CEO, said:

"The new strategy we announced on 9 June is based on an increased focus on our key franchises. We are therefore proud to announce the in-licensing of an innovative medical drug-device procedure to complement our offer in uro-oncology. Hexvix will develop commercial synergies with Decapeptyl, our GnRh analog indicated for the treatment of advanced prostate cancer and with tasquinimod currently in phase III development by our partner Active Biotech for asymptomatic or mildly symptomatic, chemotherapy-naive men with metastatic, castration-resistant prostate cancer (mCRPC). Hexvix is a unique product which considerably improves the detection of bladder cancers and ameliorates our offer in uro-oncology for the benefit of patients, prescribers and all stakeholders".

GE Healthcare has held the licence to market, sell and distribute Hexvix since 2006.  GE Healthcare continues to have the highest confidence in the product, but since urology is not a core business area for the company, Photocure has renegotiated the global licensing agreement enabling it to license the marketing rights for Hexvix to Ipsen and to commercialise the product directly in the US.

Stephen Lightfoot, COO, Medical Diagnostics, GE Healthcare said:

"We have had a successful collaboration with Photocure and are proud to have launched Hexvix/Cysview and to have worked with the product over the last six years. Urology is not a core business area for GE Healthcare and we believe a company that is dedicated to urology will be better placed to enable Hexvix to reach its full market potential and benefit more patients."

About Hexvix

Hexvix/Cysview ((hexaminolevulinate hydrochloride) for intravesical solution), is the first approved drug-device procedure for improved detection of bladder cancer.  It is designed to induce fluorescence in the malignant cells in the bladder during a cystoscopic pr
'/>"/>

SOURCE Photocure ASA
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Photocure Announces Positive Allumera™ Trial Results for Delivering Significant Skin Appearance Improvements
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
8. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
9. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
11. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... 23, 2014 UBM Medica US today announced ... online community and information resource for neurologists and other ... their patients with neurological disorders . ... population, necessitates greater access to dedicated information for healthcare ... neurological conditions include: , 1 in 6 ...
(Date:7/23/2014)... Research and Markets has announced the addition ... Application, Sensor Type & by Geography - Analysis & ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... consumer healthcare monitoring and sensing driven by sensors with ... the healthcare cost of the patient by reducing the ...
(Date:7/23/2014)... , July 23, 2014 Research ... "Diagnostic Electrocardiograph (ECG) Market by Product, End-user & by ... to their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... is segmented into three major segments, namely, holter monitor, ... market was valued at $3,683 million in 2013 and ...
Breaking Medicine Technology:UBM Medica US Launches NeurologyTimes.com 2UBM Medica US Launches NeurologyTimes.com 3Sensor Market in Consumer Healthcare (Patient Monitoring, Therapeutic, Handheld and Homecare, & Fitness and wellness) - Analysis & Forecast to to 2013 - 2020 2Sensor Market in Consumer Healthcare (Patient Monitoring, Therapeutic, Handheld and Homecare, & Fitness and wellness) - Analysis & Forecast to to 2013 - 2020 3Global Diagnostic Electrocardiograph (Resting, Stress, Holter Monitor) (ECG) Market - Forecast to 2020 2Global Diagnostic Electrocardiograph (Resting, Stress, Holter Monitor) (ECG) Market - Forecast to 2020 3
... NEW YORK, Nov. 17, 2010 Reportlinker.com announces ... in its catalogue: Healthcare Reform: ... http://www.reportlinker.com/p0325506/Healthcare-Reform-2010-Medical-Device-Industry-Perceptions-Survey.html The objective ... of the healthcare reform, evaluate what parts in ...
... YORK and NORTH BRUNSWICK, N.J., Nov. 17, 2010 ... and Fast Forward, LLC , the National ... research and drug development, today announced an expansion of their ... drug, PV-267.  This novel, highly selective small molecule is designed ...
Cached Medicine Technology:Reportlinker Adds Healthcare Reform: 2010 Medical Device Industry Perceptions Survey 2Fast Forward, LLC and Provid Pharmaceuticals Announce Expansion of their Partnership for the Development of PV-267, Provid's Unique MS Drug Candidate 2Fast Forward, LLC and Provid Pharmaceuticals Announce Expansion of their Partnership for the Development of PV-267, Provid's Unique MS Drug Candidate 3
(Date:7/24/2014)... 2014 Debt Management Credit Counseling ... organization (DMCC), announced today that it is providing ... student loan borrowers identify and implement affordable repayment ... repayment options to borrowers who are struggling to ... the corresponding repayment terms, depend on many economic ...
(Date:7/24/2014)... July 24, 2014 Seacoast Medical ... range of pharmaceutical products to Blackmaple Group Purchasing ... practices can benefit from preferential pricing through Seacoast’s ... rapidly, building on a simple, straightforward value proposition,” ... offer deep savings on items our members use ...
(Date:7/23/2014)... 24, 2014 The routine use ... greatly increases the likelihood of performing the correct ... cancer, report researchers from the University of Pittsburgh ... The test, available at the UPMC/UPCI Multidisciplinary Thyroid ... chances of patients getting the correct initial surgery ...
(Date:7/23/2014)... NY (PRWEB) July 23, 2014 The ... billion dollars by the year 2020, according to recent ... are among the top sellers in the U.S. and ... best wrinkle cream under $100 is now reviewed at ... to help a first-time or experienced shopper to compare ...
(Date:7/23/2014)... Obtaining insurance information using offline strategies ... The Quotes Pros company is launching its finder for ... year to make research faster at http://quotespros.com/life-insurance.html . ... information are actual agencies that specialize in term, whole ... An advantage to adults who use the search platform ...
Breaking Medicine News(10 mins):Health News:Nonprofit Debt Management Credit Counseling Providing Low Cost Student Loan Help 2Health News:Nonprofit Debt Management Credit Counseling Providing Low Cost Student Loan Help 3Health News:Seacoast Medical Partners with Blackmaple Group to Provide Members Cost Savings on Wide Range of Pharmaceutical Products 2Health News:UPMC-Developed Test Increases Odds of Correct Surgery for Thyroid Cancer Patients 2Health News:UPMC-Developed Test Increases Odds of Correct Surgery for Thyroid Cancer Patients 3Health News:UPMC-Developed Test Increases Odds of Correct Surgery for Thyroid Cancer Patients 4Health News:Best Wrinkle Cream Under $100 Reviewed at Top News Website Online 2Health News:Term Life Insurance Prices for All 50 States Now Explored at Insurer Website 2
... HealthDay Reporter , THURSDAY, July 29 (HealthDay News) ... the middle class? Will panels decide what care very sick, ... crowd. A new Harris Interactive/HealthDay poll shows confusion still ... law by President Barack Obama back in March. More ...
... Spanish . , Mushrooms are among the many ... immune system healthy. Now, Agricultural Research Service (ARS)-funded scientists have ... mushrooms enhanced the activity of critical cells in the body,s ... represent 90 percent of the total mushrooms consumed. The ...
... By Steven Reinberg HealthDay Reporter , ... therapeutic prostate cancer vaccine extended the lives of men ... new study shows. The vaccine, called Provenge (sipuleucel-T), ... treatment and involved less toxicity than chemotherapy. However, with ...
... HealthDay Reporter , WEDNESDAY, July 28 (HealthDay ... at bay, possibly because it dampens the body,s immune ... protect people who already have the autoimmune disease from ... a new concept. There have been other articles [stating] ...
... have discovered that a particular family of enzymes are ... production of toxic fragments that lead to the pathology ... new targets for drug therapies for the disease ... cancer drugs currently in clinical development. Results of the ...
... of California, San Francisco propose that treatments used on ... transplantation may be appropriate for all patients with hepatocellular ... appear in the August issue of Liver Transplantation ... the American Association for the Study of Liver Diseases ...
Cached Medicine News:Health News:Americans Still Confused About Health Reform 2Health News:Americans Still Confused About Health Reform 3Health News:Americans Still Confused About Health Reform 4Health News:Vaccine Boosts Survival for Men With Advanced Prostate Cancer: Study 2Health News:Vaccine Boosts Survival for Men With Advanced Prostate Cancer: Study 3Health News:Could Drinking Help Thwart Rheumatoid Arthritis? 2Health News:Could Drinking Help Thwart Rheumatoid Arthritis? 3Health News:Leap forward in efforts to develop treatments for Huntington's disease 2Health News:New transplantation criteria for liver cancer patients 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: